Important Safety Information

 

Last Updated: July 24, 2025

The oral tirzepatide formulation offered through BetterMe Rx is a compounded medication. It is not FDA-approved, and there is currently no FDA-approved oral tirzepatide product available on the market.

What Is Compounded Oral Tirzepatide?

This medication is custom-prepared by licensed compounding pharmacies in tablet or capsule form. It is intended for patients with valid prescriptions who require an alternative to injectable forms due to preference or clinical needs. It is not manufactured by Eli Lilly, the producer of Zepbound® and Mounjaro®.

Not FDA-Approved

This compounded oral tirzepatide has not been reviewed or approved by the FDA for safety, effectiveness, or manufacturing quality. It may differ significantly in how it is absorbed and metabolized compared to injectable forms.

Use and Oversight

Use only as prescribed by a licensed healthcare provider. As with all compounded medications, clinical outcomes may vary. Potential side effects include gastrointestinal symptoms (nausea, vomiting, diarrhea), headache, and other reactions.

Pharmacy Fulfillment

All compounded oral tirzepatide is prepared by licensed 503A or 503B pharmacies in accordance with applicable federal and state compounding laws.